{"id":"W2272598965","doi":"10.1200/jco.2010.28.15_suppl.4079","title":"Comorbidity and overall survival (OS) in patients with advanced pancreatic cancer (APC): Results from NCIC CTG PA.3-A phase III trial of erlotinib plus gemcitabine (E+G) versus gemcitabine (G) alone.","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Comorbidity; Internal medicine; Gemcitabine; Erlotinib; Proportional hazards model; Univariate analysis; Cancer; Oncology; Multivariate analysis; Epidermal growth factor receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002072129,0.0003246846,0.0007262681,0.0003028426,0.0002509117,0.0005013319,0.00033575,0.0004991191,0.001064887],"category_scores_gemma":[0.001800381,0.00013211,0.00110804,0.0005893222,0.0002670031,0.0003403669,0.0004014543,0.0008353409,0.0001376716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005413048,"about_ca_system_score_gemma":0.0006042703,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001805792,"about_ca_topic_score_gemma":0.003309579,"domain_scores_codex":[0.9994438,0.0003207753,0.00004241762,0.00006239119,0.00007587561,0.00005465803],"domain_scores_gemma":[0.9984608,0.000468778,0.0004710107,0.00007465953,0.0000765647,0.0004483397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3738306,0.00242349,0.5668641,0.0004790062,0.003456767,0.0001767708,0.0001047955,0.00211236,0.003386626,0.00006768892,0.00248199,0.04461577],"study_design_scores_gemma":[0.02017871,0.04173129,0.9316288,0.00006316068,0.002427184,0.0003386677,0.00004807473,0.001499855,0.0006169907,0.00008853164,0.001354183,0.00002469526],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967256,0.00195964,0.00006161277,0.0001289496,0.00001429211,0.00005017167,0.0006729395,0.000005552982,0.0003813133],"genre_scores_gemma":[0.9975964,0.0005237454,0.0001220529,0.0001328665,0.00003441923,0.00004128835,0.001422854,0.0000025065,0.0001237738],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002072129,"threshold_uncertainty_score":0.01095855,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1154738020224915,"score_gpt":0.4736437967419324,"score_spread":0.3581699947194408,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}